Arcinova Formulation Development Info Sheet

We work with you to develop the most appropriate formulation for your product.

Arcinova, A Quotient Sciences Company, specialize in phase-appropriate formulation development to support preclinical and early-phase clinical studies. From preclinical and first-in-human (FIH) dosage forms, we tailor each solution to your molecule’s physicochemical and biopharmaceutic profile, intended route of administration, and development phase.